Search

everythinglearnresearchcommunity

for

Search:↓

Botanical treatments like saw palmetto, rosemary oil, and ginseng may help reduce hair loss in menopausal women.

Blue light might help treat skin conditions by affecting the skin's bacteria.

ANp63 is crucial for skin integrity, new filaggrin gene mutations link to eczema, hair can regrow from non-stem cells, sunburns are increasing, and glucocorticoids help treat skin allergies by affecting immune cells.

Hair loss caused by genetics and hormones; more research needed for treatments.

Male pattern hair loss may have evolved to promote younger fathers for offspring health and survival, encouraging monogamy and paternal nurturing.

Microneedling with PRP and minoxidil (5%) improves hair growth more than minoxidil (5%) alone.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

Early diagnosis and treatment of TPP can prevent complications.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

Stress can slow hair growth and affect skin color by impacting the body's stress response system.

Blocking 11β-HSD1 can lessen the harmful effects of glucocorticoids on hair growth cells.

New techniques can effectively treat aging around the eyes.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.